Drug discovery and design for complex diseases through QSAR computational methods

Curr Pharm Des. 2010;16(24):2640-55. doi: 10.2174/138161210792389252.

Abstract

There is a need for a study of the complex diseases due to their important impact on our society. One of the solutions involves the theoretical methods which are fast and efficient tools that can lead to the discovery of new active drugs specially designed for these diseases. The Quantitative Structure - Activity Relationship models (QSAR) and the complex network theory become important solutions for screening and designing efficient pharmaceuticals by coding the chemical information of the molecules into molecular descriptors. This review presents the most recent studies on drug discovery and design using QSAR of several complex diseases in the fields of Neurology, Cardiology and Oncology.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Coronary Disease / drug therapy
  • Coronary Disease / epidemiology
  • Coronary Disease / mortality
  • Drug Design*
  • Drug Discovery*
  • Drug Therapy*
  • Humans
  • Models, Biological
  • Models, Molecular
  • Molecular Conformation
  • Neoplasms / drug therapy
  • Neoplasms / mortality
  • Nervous System Diseases / drug therapy
  • Nervous System Diseases / epidemiology
  • Nervous System Diseases / mortality
  • Pharmaceutical Preparations
  • Quantitative Structure-Activity Relationship

Substances

  • Pharmaceutical Preparations